
D-Bose 0.3 Tablet MD
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview D-Bose 0.3 Tablet MD
Metformin 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose levels following meals, particularly when dietary changes and other comparable treatments prove insufficient. Administer Metformin 0.3mg just prior to eating; dosage and frequency are determined by your physician to optimize blood sugar control. Discontinue use only under your doctor's guidance; abrupt cessation may elevate blood sugar, potentially causing serious complications such as renal impairment or vision loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential. Common side effects include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Metformin alone doesn't usually cause hypoglycemia (low blood sugar), combining it with other diabetes medications (especially insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; ordinary table sugar is ineffective in such instances. Inform your doctor about any kidney or liver conditions before commencing treatment. Avoid this medication if you have bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or breastfeeding individuals should seek medical advice before use. Always disclose all other medications to ensure safe use. Limit alcohol consumption while taking this medication to minimize the risk of hypoglycemia.
Uses of D-Bose 0.3 Tablet MD
Managing Type 2 Diabetes
Major Benefits of D-Bose 0.3 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth; however, refrain from swallowing it immediately. D-Bose 0.3mg Tablet MD should be consumed on an empty stomach.
Common Side effects of D-Bose 0.3 Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use D-Bose 0.3 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing it immediately. Consume D-Bose 0.3 Tablet MD on an empty stomach.
How D-Bose 0.3 Tablet MD works:
D-Bose 0.3 MD tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining D-Bose 0.3 Tablet MD and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
The use of D-Bose 0.3 Tablet MD is typically deemed safe for pregnant individuals. Preclinical trials in animals have indicated minimal or no negative consequences for fetal development; nonetheless, research involving human subjects is currently insufficient.
Breast feedingSAFE IF PRESCRIBED
Lactation and D-Bose 0.3 Tablet MD appear compatible. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by D-Bose 0.3 mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use D-Bose 0.3 Tablet MD cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use D-Bose 0.3 Tablet MD cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take D-Bose 0.3 Tablet MD :
Should you forget a D-Bose 0.3 Tablet MD dose, omit it and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About D-Bose 0.3 Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Action Class | Alpha-glucosidase inhibitors |
